Champlain Investment Partners, LLC Insulet Corp Transaction History

Champlain Investment Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$117.35 - $167.95 $60.2 Million - $86.2 Million	-513,060 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$82.13 - $120.73 $8.6 Million - $12.6 Million	-104,730 Reduced 16.95%	513,060 $61.2 Million
Q1 2019 May 14, 2019	BUY	$72.44 - $101.87 $1.39 Million - $1.96 Million	19,210 Added 3.21%	617,790 $58.7 Million
Q4 2018 Feb 13, 2019	SELL	$73.27 - $105.19 $9.16 Million - $13.2 Million	-125,080 Reduced 17.28%	598,580 $47.5 Million
Q3 2018 Nov 13, 2018	SELL	$81.43 - $108.13 $16.4 Million - $21.8 Million	-201,555 Reduced 21.78%	723,660 $76.7 Million
Q2 2018 Aug 13, 2018	SELL	$83.27 - $101.93 $9.66 Million - $11.8 Million	-115,960 Reduced 11.14%	925,215 $79.3 Million
Q1 2018 May 14, 2018	SELL	$68.49 - $87.2 $2.39 Million - $3.05 Million	-34,935 Reduced 3.25%	1,041,175 $90.2 Million
Q4 2017 Feb 12, 2018	SELL	$55.67 - $71.8 $543,339 - $700,768	-9,760 Reduced 0.9%	1,076,110 $74.3 Million
Q3 2017 Nov 13, 2017	BUY	$49.68 - $59.46 $53.9 Million - $64.6 Million	1,085,870	1,085,870 $59.8 Million

754

63.4M

467K

639K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Champlain Investment Partners, LLC with notifications on news.